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Abstract
Background: The epidemiology of gastroesophageal reflux disease (GERD) has yet to be investigated using the
symptomatic threshold criteria recommended by the Montreal Definition. This study aimed to determine the
prevalence of symptom-defined GERD across five regions of China, and to investigate variables associated with
GERD.
Methods: A representative sample of 18 000 adults (aged 18-80 years) were selected equally from rural and urban
areas in each region (n = 1800). According to the Montreal Definition, GERD is present when mild symptoms of
heartburn and/or regurgitation occur on ≥2 days a week, or moderate-to-severe symptoms of heartburn and/or
regurgitation occur on ≥1 day a week.
Results: In total, 16 091 participants completed the survey (response rate: 89.4%) and 16 078 responses were
suitable for analysis. Applying the Montreal criteria, the prevalence of symptom-defined GERD was 3.1% and varied
significantly (p < 0.001) among the five regions (from 1.7% in Guangzhou to 5.1% in Wuhan) and between rural
and urban populations (3.8% vs 2.4%). Factors significantly associated with GERD included living in a rural area and
a family history of gastrointestinal diseases.
Conclusions: This population-based survey found that the prevalence of symptom-defined GERD in China was
3.1%, which is lower than that found in Western countries.
Background
Gastroesophageal reflux disease (GERD) is a chronic dis-
ease that is associated with a range of troublesome
symptoms, which can in turn have a significant impact
on health-related quality of life and work productivity
[1-4]. It is also associated with esophageal complications
such as reflux esophagitis and Barrett’s esophagus [1].
Interest in the epidemiology of GERD has grown dur-
ing the past few decades, but interpretation of
epidemiological studies of GERD has often been ham-
pered by the use of inconsistent symptom-based defini-
tions of the disease [5]. In 2005, Dent and colleagues
performed a systematic review of studies that defined
GERD as symptoms of heartburn and/or regurgitation
occurring on at least 1 day per week [5]. They con-
cluded that the prevalence of GERD was 10-20% in
Western countries and approximately 5% in Asia based
on this definition.
Since then, a global evidence-based consensus (the
Montreal Definition of GERD) has recommended that
in population-based surveys GERD should be defined as
symptoms of heartburn and/or regurgitation that are
either mild and occur on at least 2 days a week, or
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[1]. This was considered to be the level at which these
characteristic GERD symptoms become troublesome.
The epidemiology of symptom-defined GERD has yet to
be investigated using these threshold criteria.
We have previously validated a survey methodology
for the epidemiological study of GERD in Shanghai,
China [6-8]. Here, we report results from the Systematic
Investigation of Gastrointestinal Diseases in China
(SILC), which is a large epidemiological survey of five
regions of China [9]. The aim of the SILC study was to
use the symptom threshold recommended for epidemio-
logical studies by the Montreal Definition to determine
the prevalence of symptom-defined GERD across five
regions of China, and to investigate variables associated
with this disease.
Methods
Setting, sampling and study design
The major population centres of Shanghai, Beijing,
Xi’an, Wuhan and Guangzhou (including the rural dis-
tricts surrounding the cities) were selected for sampling
in this study. The demographic characteristics of these
areas are summarized in Table 1. Fieldwork was carried
out from April 2007 to January 2008.
As previously described [9], 18 000 residents of China
aged 18-80 years were selected randomly using a strati-
fied, multi-stage sampling methodology. Urban and
rural populations, which have distinct socioeconomic
characteristics (Additional File 1), were sampled in a
ratio of 1:1 (n = 1800 from each stratum in each region)
in proportion to the overall age and sex distribution of
each region.
All respondents completed a survey consisting of a
general information questionnaire and a Chinese version
of the Reflux Disease Questionnaire (RDQ) [7]. A ran-
dom sub-sample of 20% of the respondents in each
region was asked to undergo a physical examination
that included measurement of weight, height, and waist
and hip circumference. The residents of Shanghai were
also invited to undergo endoscopy, the results of which
are described elsewhere [10,11].
The general information questionnaire collected self-
reported information on age, height, weight, sex, marital
status, education, income, occupation, lifestyle habits,
health status, family history of gastrointestinal diseases,
and medical history (current and previous medical pro-
blems and related treatment).
The RDQ was used to determine the frequency and
severity of heartburn (defined as ‘burning behind the
breastbone’ and/or ‘pain behind the breastbone’)a n d
regurgitation (defined as ‘acid taste in the mouth’ and/or
‘unpleasant movement of materials upwards from the
stomach’) during a 1-month recall period. The frequency
and severity of each RDQ item are scored on a 6-point
Likert scale (0-5; where 0 is no symptoms, 1 is symptoms
on less than 1 day a week or very mild symptoms, and 5
is daily or severe symptoms) (Additional File 2). The
validity and reliability of the RDQ as a diagnostic tool has
been previously demonstrated [12]. The Chinese version
o ft h eR D Qu s e di nt h ep r e s e n ts t u d yu n d e r w e n te x t e n -
sive linguistic validation including forward and backward
translation, cognitive debriefing of patients with GERD,
and expert input from gastroenterologists. The pilot
study showed that a version with a 1-week recall period
had credible reliability and construct validity [7]. Apply-
ing the Montreal Definition, symptom-defined GERD
was defined as mild symptoms of heartburn and/or
regurgitation occurring on at least 2 days a week (a fre-
quency score ≥3a n das e v e r i t ys c o r eo f≥2f o ra n yo ft h e
relevant symptoms), or moderate-to-severe symptoms of
heartburn and/or regurgitation occurring on at least
1 day a week (a frequency score ≥2 and a severity score
≥3 for any of the relevant symptoms).
Participants filled out the questionnaires themselves,
either in local residential committee offices or in their
Table 1 Demographic characteristics of the population centres included in the study
Shanghai
a
(N = 13.5 m) %
Beijing
b
(N = 11.8 m) %
Wuhan
b
(N = 7.8 m) %
Xi’an
b
(N = 7.3 m) %
Guangzhou
b
(N = 7.3 m) %
Female 50.6 50.0 49.7 50.0 45.4
Urban 54.2 57.5 58.6 50.4 55.7
Age (years)
18-29 13.3 25.6 31.1 27.8 31.9
30-39 18.8 21.5 19.6 25.7 28.5
40-49 30.2 22.0 20.3 19.9 17.8
50-59 16.4 15.1 15.5 12.9 11.5
60-69 12.4 9.3 8.0 8.8 6.3
70-80 9.1 6.5 5.5 5.0 4.0
aData from the fifth population census in China (2000) [43,44].
bData from the government 1% sample survey (2005) [45-47].
m, million.
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Page 2 of 10own home, with trained and supervised facilitators avail-
able to explain any questions that were unclear.
Informed consent was obtained, and individuals were
free to discontinue their participation in the study at
any time. The study was approved by the Ethics Com-
mittee of the Second Military Medical University,
Shanghai, China.
Data collection and analysis
Data were collected and validated as previously
described, with the SAS 9.1.3 program (SAS Institute,
Cary, NC, USA) used to complete data analyses [9].
Odds ratios (ORs) and 95% confidence intervals (CIs)
were calculated by univariate and multivariate logistic
regression in order to examine factors that are poten-
tially associated with symptom-defined GERD. The
Cochran-Armitage test was used for trend testing and
the Cochran-Mantel-Haenszel test was used to compare
the baseline characteristics of respondents in the differ-
ent study centres.
Results
Response rate and sample characteristics
In total, 16 091 individuals completed the survey (a
response rate of 89.4%) and 16 078 responses (99.9%)
were suitable for analysis. In the 20% sub-sample, the
response rate was 89.4% and 3214 responses were suita-
ble for analysis (99.8%). The mean (SD) age of partici-
pants in the total study sample was 42.5 (15.2) years;
52.2% of participants were female. Body mass index
( B M I )r a n g e df r o m1 1 . 8k g / m
2 to 41.0 kg/m
2,w i t ha
mean (SD) of 22.6 kg/m
2 (3.3). The majority of partici-
pants reported that they did not drink alcohol (79.7%)
or smoke cigarettes (69.9%). The baseline characteristics
of each study centre are detailed in Additional File 3.
Approximately half of all respondents lived in the rural
areas of each of the studied provinces.
Prevalence of reflux symptoms
At least monthly symptoms of heartburn and/or regurgi-
tation were reported by 12.7% of participants (Table 2),
with regurgitation (10.8%) being more prevalent than
heartburn (4.0%). The prevalence estimates of individual
RDQ items were as follows: 8.7% for ‘an acid taste in
the mouth’,5 . 3 %f o r‘an unpleasant movement of mate-
rial upwards from the stomach’, 2.4% for ‘burning
behind the breastbone’, and 2.8% for ‘pain behind the
breastbone’. Approximately 5% of participants experi-
enced reflux symptoms on at least 1 day per week
(Table 3). Regurgitation (4.2%) remained more common
than heartburn in these participants (1.8%).
Most reflux symptoms were experienced less often
than 1 day a week, and most were very mild in severity
(Figures 1a and 1b).
Prevalence of GERD
The prevalence of symptom-defined GERD was 3.1%
overall (2.4% in urban areas and 3.8% in rural areas),
and varied among the five regions studied, from 1.7% in
Guangzhou to 5.1% in Wuhan (Table 3). The prevalence
of symptom-defined GERD in the 20% sub-sample was
3.4%.
A total of 326 participants (2.0%) reported that they
had previously been diagnosed with GERD by a physi-
cian: 73 of these met the study criteria for symptom-
defined GERD and 253 did not (Table 4). The majority
of the individuals who reported a history of GERD had
been prescribed drug therapy at some point in time
(76.1%; 248/326). The mean (SD) reported age for a first
physician diagnosis of GERD was 37.8 (14.1) years. For
almost all participants (99.7%), this physician diagnosis
was more than 5 years ago.
Factors associated with the presence of GERD
Factors found to be associated with the presence of
symptom-defined GERD in a multiple logistic regression
analysis are presented in Table 5. Participants living in
rural areas were more likely to have symptom-defined
GERD than those living in urban areas, whereas indivi-
duals aged 18-29 years were less likely to have symp-
tom-defined GERD than those aged 30-39 years.
Symptom-defined GERD was also associated with
decreasing self-reported health status and a family his-
tory of gastrointestinal disease, and was inversely asso-
ciated with recreational exercise taken at least once a
week. Compared with participants without GERD, those
with symptom-defined GERD were more likely to con-
sume alcohol and were less likely to have attained a sec-
ondary/high school educational level. In univariate
analysis, a BMI of ≥27.5 kg/m
2 was associated with a
significant increase in the risk of GERD. Trend testing
also showed a relationship between BMI and the occur-
rence of GERD (p = 0.003). However, there was no sig-
nificant association between a BMI of ≥27.5 kg/m
2 and
GERD in the multivariate analysis. Sex, smoking, occu-
pation and income were not significantly associated with
symptom-defined GERD.
Table 2 Prevalence of at least monthly symptoms of
heartburn or regurgitation (any frequency or severity)
Symptom Prevalence (%)
Heartburn or regurgitation 12.7
Regurgitation 10.8
Acid taste in the mouth 8.7
Unpleasant movement of material upwards
from the stomach
5.3
Heartburn 4.0
Burning behind the breastbone 2.4
Pain behind the breastbone 2.8
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burn of any frequency or severity (n = 638) and those
who reported regurgitation of any frequency or severity
(n = 1738), a number of differences were found in the
factors associated with regurgitation and heartburn.
Alcohol consumption was significantly associated with
the presence of regurgitation (OR: 1.34; 95% CI: 1.15-
1.55) but not heartburn (OR: 1.15; 95% CI: 0.91-1.45).
Conversely, a BMI of ≥27.5 kg/m
2 was significantly asso-
ciated with the presence of heartburn (OR: 1.47; 95% CI:
1.14-1.91) but not regurgitation (OR: 1.10; 95% CI: 0.92-
1.33). Compared with participants aged 30-39 years,
those aged 70-80 years had a significantly higher risk of
heartburn (OR: 1.45; 95% CI: 1.02-2.07) but a signifi-
cantly lower risk of regurgitation (OR: 0.70; 95% CI:
0.55-0.90). Living in a rural area, decreasing health sta-
tus and a family history of gastrointestinal disease were
associated with a significant increase in the risk of both
heartburn and regurgitation (data not shown).
No significant associations (in univariate or multivari-
ate analyses) were found between symptom-defined
GERD and BMI or waist-to-hip ratio among the 20%
sub-sample who were randomly selected to undergo a
physical examination (Table 6).
The presence of symptom-defined GERD was associated
with a self-reported history of dyspepsia (OR: 2.81; 95% CI:
2.20-3.59), dysphagia (OR: 4.56; 95% CI: 2.30-9.04), gastritis
(OR: 3.06; 95% CI: 2.46-3.81) or peptic ulcer disease (OR:
2.05; 95% CI: 1.52-2.76). There was no significant associa-
tion between GERD and self-reported irritable bowel syn-
drome (OR: 0.53; 95% CI: 0.12-2.42). Self-reported joint
disorders (OR: 2.03; 95% CI: 1.58-2.61) and chronic cough
(OR: 2.14; 95% CI: 1.39-3.28) were associated with GERD,
whereas asthma (OR: 0.87; 95% CI: 0.39-1.94), hoarseness
(OR: 0.76; 95% CI: 0.38-1.55) and non-cardiac chest pain
(OR: 1.54; 95% CI: 0.72-3.31) were not.
Discussion
This large multicentre study of the epidemiology of
symptom-defined GERD surveyed a total population of
18 000 individuals from five regions across China. To
our knowledge, it is the first epidemiological study any-
where in the world to apply the symptom-based criteria
recommended by the Montreal Definition of GERD for
use in population-based studies [1]. The overall preva-
lence of symptom-defined GERD in the present study
Table 3 Regional variation in the prevalence of reflux symptoms and symptom-defined gastroesophageal reflux
disease (GERD)
Population Reflux symptoms at least monthly
n (%)
Reflux symptoms at least weekly
n (%)
Symptom-defined GERD
a
n (%)
Shanghai (n = 3151) 338 (10.7) 143 (4.5) 84 (2.7)
Beijing (n = 3168) 287 (9.1) 120 (3.8) 69 (2.2)
Wuhan (n = 3283) 532 (16.2) 245 (7.5) 169 (5.1)
Xi’an (n = 3266) 609 (18.6) 218 (6.7) 121 (3.7)
Guangzhou (n = 3210) 271 (8.4) 103 (3.2) 53 (1.7)
Total (n = 16 078) 2037 (12.7) 829 (5.2) 496 (3.1)
aDefined as mild symptoms of heartburn and/or regurgitation occurring on at least 2 days a week (Reflux Disease Questionnaire [RDQ] item frequency score ≥3
for a severity score of ≥2), or moderate-to-severe symptoms of heartburn and/or regurgitation occurring on at least 1 day a week (RDQ item frequency score ≥2
for a severity score ≥3).
Figure 1 Prevalence of reflux symptoms by (a) frequency and
(b) severity (n = 16 078).
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regions studied, from 1.7% in Guangzhou to 5.1% in
Wuhan, which emphasizes the cultural and demographic
variability in this vast country and suggests that future
epidemiological studies should not extrapolate findings
in one area to the country as a whole.
Overall, 2% of study participants reported a pre-existing
GERD diagnosis, and 76.1% of these individuals had
received drug treatment for GERD, although the details of
this treatment (e.g. drug name, dose and period of admin-
istration) were not recorded. Of those participants who
had been diagnosed and treated for GERD, 77.0% did not
reach the symptom threshold criteria for GERD used in
this study, perhaps because their treatment was successful
in controlling their symptoms. Conversely, 85.3% of parti-
cipants who met symptom-defined GERD criteria had not
been previously diagnosed with GERD. This suggests that
consultation for reflux symptoms in this population is low,
despite the negative impact that the symptoms are known
to have on health-related quality of life [13].
The prevalence of symptom-defined GERD reported in
the current study was lower than that found in the pilot
study in Shanghai (6.2%) [6]. This is likely to be because
the pilot study used a simple frequency threshold of
reflux symptoms on at least 1 day a week to define
GERD whereas the present study, in accordance with
the Montreal Definition, excluded very mild symptoms
of any frequency and mild symptoms on only 1 day a
week from the definition of GERD.
The prevalence of GERD was comparable to or lower
than that found in previous Chinese population-based
surveys that used a variety of definitions of GERD (2.4-
17.0%) [6,14-20], again reflecting the conservative defini-
tion used in the SILC study. The prevalence of symp-
toms of heartburn and/or regurgitation on at least 1
day a week was 5.2% in the SILC study, compared with
2.5-12.9% in previous studies conducted in China
[6,14-20].
Despite the variation in the prevalence of GERD
across the study centres, our results add weight to the
conclusion that there is a lower prevalence of symptom-
defined GERD in China (below 5%) than in Western
countries (10-20%) [5]. This is mostly a result of a lower
prevalence of heartburn (1.9-4.1% vs 7.7-17.8%) rather
than regurgitation (5.5-7.8% vs 6.3-14.5%) in China
[15,16] compared with Western populations [21]. Heart-
burn has also been found to be less common than
regurgitation in Iran [22] and Turkey [23]. The reason
for these differences in symptom patterns is unclear.
They could be a result of genetic or pathophysiological
differences between Western and Asian populations,
although the evidence for this is limited [21]. The term
heartburn is also less well understood in China than in
Western countries. However, the linguistic validation
performed as part of the current study [9] should have
minimized the effect of such cultural differences.
Factors associated with GERD
The factors most strongly associated with symptom-
defined GERD were declining self-reported health status
and a family history of gastrointestinal disease. Self-
reported health status is known to be an accurate pre-
dictor of morbidity and mortality in China and other
Asian populations as well as worldwide [24,25], and the
association we observed may reflect the burden of symp-
toms and comorbidity in individuals with GERD. An
association of GERD with a relevant family history has
been seen in previous studies [5,26], and the results of
twin studies in Sweden and the UK have also provided
evidence of a genetic component to the disease [27-29].
In support of this genetic association, a recent study
found an association between GERD and the gene
encoding collagen type III alpha 1 (COL3A1) [30].
We also found that individuals living in a rural area
had a higher risk of GERD than those living in an urban
area. The reasons for this are unclear, and previous stu-
dies in China do not provide consistent support for this
association. Pan et al. found that GERD was more com-
mon in rural than urban areas in Beijing (12.5% vs 8.6%)
but that the reverse was true in Shanghai (7.0% vs 8.6%)
[20]. Wang et al. found that GERD was more common
in urban (21.1%) than rural (17.4%) areas of Xi’an [16].
Table 4 Self-reported history of GERD and treatment in participants with and without symptom-defined GERD.
Medical history of GERD With symptom-defined GERD
a
(n = 496)
n (%)
Without symptom-defined GERD
a
(n = 15 582)
n (%)
None 423 (85.3) 15 328 (98.4)
Previously diagnosed 73 (14.7) 253 (1.6)
Treated
b 57 (11.5) 191 (1.2)
Not treated 16 (3.2) 60 (0.4)
GERD, gastroesophageal reflux disease; RDQ, Reflux Disease Questionnaire.
aDefined as mild symptoms of heartburn and/or regurgitation occurring on at least 2 days a week (RDQ item frequency score ≥3 for a severity score of ≥2), or
moderate-to-severe symptoms of heartburn and/or regurgitation occurring on at least 1 day a week (RDQ item frequency score ≥2 for a severity score ≥3).
bDrug treatment (excluding traditional Chinese medicine).
NOTE: numbers may not add up exactly where individual participants have refused to answer specific questions on the general information questionnaire.
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symptom-defined GERD
With symptom-defined
GERD
a (n = 496)
n (%)
Without symptom-defined
GERD
a (n = 15 582)
n (%)
Univariate OR
(95% CI)
Multivariate OR
b
(95% CI)
Environment
Urban 192 (38.7) 7880 (50.6) 1.00 1.00
Rural 304 (61.3) 7702 (49.4) 1.62 (1.35-1.95) 1.40 (1.13-1.72)
Sex
Female 282 (56.9) 8108 (52.0) 1.00 1.00
Male 214 (43.1) 7474 (48.0) 0.82 (0.69-0.99) 1.00 (0.77-1.29)
Age (years)
18-29 48 (9.7) 3632 (23.3) 0.49 (0.34-0.69) 0.67 (0.46-0.97)
30-39 97 (19.6) 3578 (23.0) 1.00 1.00
40-49 129 (26.0) 3683 (23.6) 1.29 (0.99-1.69) 1.11 (0.84-1.47)
50-59 113 (22.8) 2355 (15.1) 1.77 (1.34-2.33) 1.20 (0.89-1.62)
60-69 59 (11.9) 1444 (9.3) 1.51 (1.08-2.09) 0.82 (0.57-1.18)
70-80 50 (10.1) 890 (5.7) 2.07 (1.46-2.94) 0.85 (0.57-1.27)
BMI (kg/m
2)
c
<18.5 44 (8.9) 1436 (9.2) 1.10 (0.79-1.53) 1.04 (0.73-1.48)
18.5-22.9 209 (42.1) 7512 (48.2) 1.00 1.00
23.0-27.4 181 (36.5) 5326 (34.2) 1.22 (1.00-1.50) 1.14 (0.92-1.41)
≥27.5 58 (11.7) 1244 (8.0) 1.68 (1.25-2.26) 1.32 (0.97-1.80)
Education
None/primary school 183 (36.9) 2999 (19.2) 1.00 1.00
Secondary/high school 255 (51.4) 9675 (62.1) 0.43 (0.36-0.52) 0.62 (0.49-0.79)
College graduates or beyond 58 (11.7) 2906 (18.6) 0.33 (0.24-0.44) 0.69 (0.45-1.05)
Occupation
Office worker 96 (19.4) 4116 (26.4) 1.00 1.00
Manual worker 400 (80.6) 11 445 (73.4) 1.50 (1.20-1.88) 0.88 (0.67-1.17)
Total monthly family income (yuan)
d
≤1999 325 (65.5) 8490 (54.5) 1.00 1.00
2000-4999 139 (28.0) 5824 (37.4) 0.62 (0.51-0.76) 0.83 (0.67-1.04)
≥5000 31 (6.3) 1228 (7.9) 0.66 (0.45-0.96) 0.92 (0.61-1.39)
Smoking status
Never smoker 355 (71.6) 10 875 (69.8) 1.00 1.00
Current smoker 122 (24.6) 4309 (27.7) 0.87 (0.70-1.07) 0.80 (0.60-1.06)
Ex-smoker 19 (3.8) 395 (2.5) 1.47 (0.92-2.36) 0.95 (0.56-1.61)
Alcohol consumption
e
No 393 (79.2) 12 420 (79.7) 1.00 1.00
Yes 103 (20.8) 3159 (20.3) 1.03 (0.83-1.28) 1.31 (1.00-1.71)
Frequency of recreational exercise
Daily 350 (70.6) 10 009 (64.2) 1.00 1.00
At least weekly but less than daily 45 (9.1) 2149 (13.8) 0.60 (0.44-0.82) 0.68 (0.49-0.94)
Less than weekly 33 (6.7) 1330 (8.5) 0.71 (0.49-1.02) 0.87 (0.60-1.27)
Never 65 (13.1) 2066 (13.3) 0.90 (0.69-1.18) 0.81 (0.61-1.07)
Self-reported health status
Very good 11 (2.2) 1759 (11.3) 1.00 1.00
Good 110 (22.2) 7471 (47.9) 2.35 (1.26-4.39) 2.33 (1.21-4.47)
Moderate 245 (49.4) 5558 (35.7) 7.05 (3.84-12.93) 6.43 (3.39-12.22)
Poor 121 (24.4) 741 (4.8) 26.11 (14.00-48.69) 20.10 (10.33-39.13)
Very poor 8 (1.6) 50 (0.3) 25.59 (9.86-66.37) 22.47 (8.34-60.52)
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between obesity and heartburn, but not between obesity
and symptom-defined GERD; however, the pilot study
using a less stringent definition of GERD did find a posi-
tive association with obesity [6]. Previous population-
based studies that looked at the association of GERD
with BMI in China have also reported inconsistent results
[6,14-20]. This contrasts with the increasingly clear asso-
ciation between GERD and obesity that has been found
in Western countries, particularly in the USA [31-34]. It
is possible that this reflects differences in the prevalence
of other etiological factors such as hiatus hernia or per-
haps the low prevalence of obesity in China.
Association of GERD with self-reported medical history
The current results support an association of GERD with a
history of peptic ulcer disease [16,35-37], but do not sup-
port associations seen in Europe between GERD and
irritable bowel syndrome or asthma [36,38,39] or a protec-
tive effect for gastritis against GERD [40]. It is, however,
important to distinguish between objectively demonstrated
gastritis and the patient-reported history of gastritis that is
reported in the present study. In Asian countries ‘gastritis’
commonly denotes upper gastrointestinal discomfort and
a diagnosis is unlikely to be based on endoscopic biopsy or
serum pepsinogen measurement. GERD was associated
with chronic cough in our study, supporting the estab-
lished association with this extraesophageal syndrome [1].
The association we found between joint disorders
(rheumatoid arthritis and osteoarthritis) and GERD may
reflect the use of non-steroidal anti-inflammatory drugs
(NSAIDs) for pain relief in this population [41].
Strengths and limitations
This large, population-based, epidemiological study pro-
vides high-quality data on the prevalence of GERD in
Table 5 Characteristics of participants with and without symptom-defined GERD, and their association with symptom--
defined GERD (Continued)
Family history of GI diseases
No 392 (79.0) 14 252 (91.5) 1.00 1.00
Yes 104 (21.0) 1323 (8.5) 2.86 (2.29-3.57) 2.59 (2.05-3.28)
BMI, body mass index; CI, confidence interval; GERD, gastroesophageal reflux disease; GI, gastrointestinal; OR, odds ratio; RDQ, Reflux Disease Questionnaire.
aDefined as mild symptoms of heartburn and/or regurgitation occurring on at least 2 days a week (RDQ item frequency score ≥3 for a severity score of ≥2), or
moderate-to-severe symptoms of heartburn and/or regurgitation occurring on at least 1 day a week (RDQ item frequency score ≥2 for a severity score ≥3).
bAdjusted by all variables in the table.
cBMI ranges are appropriate for the Asian population (underweight: < 18.5 kg/m
2; normal: 18.5-22.9 kg/m
2; overweight: 23.0-27.4 kg/m
2; obese: ≥27.5 kg/m
2) [48].
dAverage yearly income in China in 2007: 24 932 yuan (~$3300) [42].
eDefined as alcohol consumed on at least four occasions per month.
NOTE: all data were generated from the general information questionnaire; numbers may not add up exactly where individual participants have refused to
answer specific questions.
Table 6 Association of symptom-defined GERD with BMI and waist-to-hip ratio in participants who underwent a
physical examination (20% sub-sample, n = 3214)
With symptom-defined GERD
a
(n = 110)
n (%)
Without symptom-defined GERD
a
(n = 3104)
n (%)
Univariate OR
(95% CI)
Multivariate OR
b
(95% CI)
BMI (kg/m
2)
c
<18.5 7 (6.4) 270 (8.7) 0.83 (0.37-1.85) 1.01 (0.45-2.29)
18.5-22.9 47 (42.7) 1504 (48.5) 1.00 1.00
23.0-27.4 41 (37.3) 1042 (33.6) 1.26 (0.82-1.93) 1.07 (0.68-1.68)
≥27.5 15 (13.6) 287 (9.2) 1.67 (0.92-3.03) 1.27 (0.65-2.46)
Waist-to-hip ratio
Men: <0.90;
women: <0.83
56 (50.9) 1801 (58.0) 0.86 (0.55-1.35) 1.10 (0.68-1.79)
Men: 0.90-0.95;
women: 0.83-0.90
31 (28.2) 859 (27.7) 1.00 1.00
Men: >0.95;
women: >0.90
23 (20.9) 414 (13.3) 1.54 (0.89-2.67) 1.42 (0.79-2.53)
BMI, body mass index; CI, confidence interval; GERD, gastroesophageal reflux disease; OR, odds ratio; RDQ, Reflux Disease Questionnaire.
aDefined as mild symptoms of heartburn and/or regurgitation occurring on at least 2 days a week (RDQ item frequency score ≥3 for a severity score of ≥2), or
moderate-to-severe symptoms of heartburn and/or regurgitation occurring on at least 1 day a week (RDQ item frequency score ≥2 for a severity score ≥3).
bAdjusted by age, sex and all variables in the table.
cBMI ranges are appropriate for the Asian population (underweight: < 18.5 kg/m
2; normal: 18.5-22.9 kg/m
2; overweight: 23.0-27.4 kg/m
2; obese: ≥27.5 kg/m
2) [48].
NOTE: BMI data were missing for 1 participant, and waist-to-hip ratio data were missing for 30 participants.
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Page 7 of 10five geographically diverse regions of China. Key
strengths are the large sample size, the use of a validated
symptom questionnaire and survey methodology, and
also the use of a symptom-based definition of GERD
that was built on global consensus. Importantly, the
population sampling and survey administration methods
achieved a high response rate (89.4%) that minimized
the potential for responder bias and generated represen-
tative adult population samples [9]. In addition, by gath-
ering data on treatment history, it was possible to gain
insight into how existing treatment of GERD may affect
prevalence data.
Samples sizes were equal for rural and urban popula-
tions and for each population region, and were not
weighted in proportion to the actual population size.
However, available data indicate that the mean ratio of
urban to rural people for all five study regions was
approximately 0.81:1, ranging from 0.71:1 (in Wuhan) to
0.98:1 (in Beijing) [9] and in China overall this ratio was
approximately 0.82:1 in 2007 [42]. Therefore we con-
sider the urban and rural strata in this study to be suffi-
ciently representative of the five study regions.
Language barriers and cultural differences are inevita-
ble study limitations, although every effort was made to
overcome these through the survey administration tech-
niques and the linguistic validation of questionnaires [9].
Another potential limitation is that the medical history
of participants was self-reported, although it should be
n o t e dt h a ti ti ss t a n d a r dp r a c t i c ei nC h i n af o rp a t i e n t s
to keep their own medical records which may reduce
the impact of this limitation.
Further study
Further investigation into potential risk factors and
comorbidities associated with GERD is warranted, ide-
ally in relation to incident cases of GERD. Ascertaining
details of the drug treatments used by participants for
diagnosed conditions would be of value in future stu-
dies, particularly use of NSAIDs, acetylsalicylic acid, tra-
ditional herbal remedies and treatments for GERD.
Further research is needed to clarify whether the preva-
lence of GERD is increasingi nC h i n a ,a n dt h ef a c t o r s
that may be associated with such an increase.
Conclusions
This study suggests that the prevalence of symptom-
defined GERD is lower in China than in Western coun-
tries. This is mostly a result of a lower prevalence of
heartburn rather than regurgitation in China compared
with Western populations. The prevalence of symptom-
defined GERD varies widely across China, which argues
that future studies should not extrapolate findings in
one area to the country as a whole.
Additional material
Additional file 1: Baseline characteristics of respondents in urban
and rural regions.
Additional file 2: Scoring system of the Reflux Disease
Questionnaire (RDQ).
Additional file 3: Baseline characteristics of respondents in each
study centre, and the results of Cochran-Mantel-Haenszel trend
testing comparing the prevalence of these characteristics across
the study centres.
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